Jacob White

jwhite@dcat.org

LATEST

Balancing Innovation and Industrialization in a Growth Company—Reflecting on 2022 with Nanoform’s Chief Commercial Officer Christian Jones

It is one thing to launch a company on the basis of game-changing innovation and attract initial interest and funding, but quite another to grow it into an enduring success.…

Supplier News: Axplora, MilliporeSigma, Cytiva & More
By

By
The latest from CDMOs, CMOs, and suppliers featuring MilliporeSigma, Cytiva, Fujifilm Diosynth Biotechnologies, Kindeva Drug Delivery, Meridian Medical Technologies, WuXi Vaccines and Axplora. Chemicals/Chemical API Manufacturing* Novasep-PharmaZell Renamed as AxploraBiologics…

Mfg News: GSK, Pfizer, BioNTech, Novartis & Lupin
By

By
A roundup of manufacturing news from GlaxoSmithKline, Pfizer, BioNTech, Novartis, and Lupin. Highlights below. * GSK Opens $33-M High-Potency Mfg Facility* Pfizer To Divest Sterile Injectable Mfg Facility to Bridgewest Group*…

Global Briefs: Sanofi, AstraZeneca & More
By

By
A roundup of news from Sanofi, Insilico Medicine, AstraZeneca and LogicBio. Highlights below. * Sanofi, Insilico Medicine in $1.2 Bn AI Drug Discovery Pact* AstraZeneca Completes $68-M Acquisition of Gene-Therapy…

COVID News: FDA, Moderna, Sanofi, GSK, Pfizer & More
By

By
The latest on COVID-19 vaccines/drugs and manufacturing from the FDA, Moderna, Sanofi, GlaxoSmithKline, Pfizer, BioNTech and Daiichi Sankyo. Highlights below. Updates on COVID-19 Vaccines and Therapeutics* FDA Commissioner Tests Positive…

Viatris To Acquire Two Ophthalmology Companies for Up To $750 M; Updates Divestments
By

By
Viatris has agreed to acquire two ophthalmology drug companies for a combined total of between $700 million and $750 million: Oyster Point Pharma, a Princeton, New Jersey-based bio/pharmaceutical company, and…

Biogen Names New CEO & President
By

By
Biogen’s Board of Directors has appointed Christopher A. Viehbacher, former CEO of Sanofi and most recently co-founded Gurnet Point Capital, a healthcare investment fund, as President and CEO and a…

Six Pharma Majors Roll out Priorities in Industry Net-Zero Emission Initiative
By

By
CEOs from six large bio/pharmaceutical companies—AstraZeneca, GlaxoSmithKline, Merck KGaA, Novo Nordisk, Roche, and Sanofi—and Samsung Biologics, a biologics CDMO have announced joint action under the Sustainable Markets Initiative (SMI) Health…

Supplier News: Alcami, Charles River Labs, Ortec & More
By

By
The latest from CDMOs, CMOs, and suppliers featuring Alcami, Charles River Laboratories, Ortec, ReiThera, iBio, Wheeler Bio, and Terumo.   Chemicals/Chemical API Manufacturing* Ortec Opens New European HQ, Mfg CenterBiologics…

Mfg News: Abraxis, Lupin, Sandoz & Allogene Overland
By

By
A roundup of manufacturing news from Abraxis Bioscience, Lupin, Sandoz, and Allogene Overland Biopharm. Highlights below. * FDA Issues Warning Letter to BMS Subsidiary Abraxis Bioscience* FDA Issues Warning Letter to…